ClinChoice Executive and Leadership Team

November, 2026

Leadership Overview

ClinChoice has 6 executives leading key functions including corporate strategy, international operations, global governance, regional management, clinical revenue, and biometrics.

Focused on accelerating drug and device approvals, ClinChoice delivers comprehensive research services to improve global health outcomes through rigorous scientific standards and efficient development pathways.

Leadership Roles at ClinChoice

  • Chairman & Chief Executive Officer - Kevin Xu
  • ClinChoice International Chief Executive Officer - John Balian
  • Global Chief Executive Officer & Chairman, Board - Ling Zhen
  • President, Global Biometrics - Tiepu Liu
  • Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto - Stephen Abella
  • Managing Director - Davit Abrahamyan
  • Kevin Xu - Chairman & Chief Executive Officer

    Kevin Xu, the Chairman & Chief Executive Officer at ClinChoice, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the expansion of full-service CRO capabilities, the Chairman & Chief Executive Officer ensures that drug and device development processes meet stringent global regulatory requirements. This leadership role involves constant engagement with the Board to align operational goals with the mission of accelerating market access for life-saving therapies. Kevin Xu maintains a focus on scaling infrastructure to support complex clinical trials across diverse therapeutic areas. Through the implementation of high-level governance frameworks, the Chairman & Chief Executive Officer drives organizational excellence and fosters a culture of innovation. Ultimately, the executive secures the company's position as a premier partner for pharmaceutical and medical device companies seeking efficient, reliable, and compliant research solutions on a global scale.

    John Balian - ClinChoice International Chief Executive Officer

    John Balian, the ClinChoice International Chief Executive Officer at ClinChoice, manages the strategic growth and operational execution of international business units. Overseeing the expansion of service offerings across diverse global markets, the ClinChoice International Chief Executive Officer ensures that regional teams maintain alignment with the core mission of accelerating drug and device approvals. This leadership role involves coordinating cross-border clinical operations to optimize efficiency and regulatory compliance for international clients. John Balian drives the integration of local expertise into the broader global framework, facilitating seamless project delivery. By monitoring market trends and competitive dynamics, the ClinChoice International Chief Executive Officer identifies opportunities for sustainable growth and service enhancement. Through the management of international partnerships and client relationships, Balian strengthens the company's footprint, ensuring that global research initiatives consistently deliver high-quality data and support for medical advancements worldwide.

    Ling Zhen - Global Chief Executive Officer & Chairman, Board

    Ling Zhen, the Global Chief Executive Officer & Chairman, Board at ClinChoice, architects the strategic direction and governance standards for the entire organization. Overseeing global operations, the Global Chief Executive Officer & Chairman, Board ensures that all clinical research activities adhere to the highest quality benchmarks while accelerating time-to-market for critical medical products. This leadership role involves guiding the Board through complex decision-making processes regarding capital allocation and long-term business development. Ling Zhen drives the implementation of advanced operational models that enhance productivity across all service lines. By fostering collaboration between internal departments and external stakeholders, the Global Chief Executive Officer & Chairman, Board maintains a focus on delivering superior value to clients. Through the oversight of global performance metrics, Zhen ensures that the company remains at the forefront of the CRO industry, consistently contributing to a safer and better world.
    Ling Zhen

    Tiepu Liu - President, Global Biometrics

    Tiepu Liu, the President, Global Biometrics at ClinChoice, leads the strategic development and execution of biostatistical and data management services. Overseeing the global biometrics division, the President, Global Biometrics ensures that all clinical data analysis meets the rigorous standards required for regulatory submissions of drugs and devices. This leadership role involves managing large-scale data operations and implementing advanced analytical methodologies to support clinical trial success. Tiepu Liu drives the integration of innovative technology into biometric processes to enhance data accuracy and speed. By collaborating with other C-suite leaders, the President, Global Biometrics aligns data-driven insights with the company's overall mission of accelerating market approvals. Through the supervision of global teams, Liu ensures that biometrics services remain a core strength of the organization. The President, Global Biometrics consistently delivers high-quality statistical support, enabling clients to navigate complex regulatory environments with confidence and precision.
    Tiepu Liu

    Stephen Abella - Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto

    Stephen Abella, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto at ClinChoice, directs the financial strategy and revenue growth initiatives within the clinical operations division. Overseeing the alignment of project coordination with revenue targets, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto ensures that operational activities remain profitable while meeting client expectations for drug and device approval timelines. This leadership role involves managing the financial health of clinical projects and ensuring that all operations comply with the necessary regulatory qualifications. Stephen Abella drives the development of revenue-generating strategies that leverage the company's full-service capabilities. By monitoring project performance and resource allocation, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto optimizes the financial outcomes of complex research programs. Abella ensures that the company maintains a strong competitive position through disciplined financial management and operational efficiency.
    Stephen Abella

    Davit Abrahamyan - Managing Director

    Davit Abrahamyan, the Managing Director at ClinChoice, oversees regional operational performance and ensures the successful delivery of clinical research services. Managing the day-to-day execution of complex projects, the Managing Director aligns local resources with the company's global standards for drug and device development. This leadership role involves supervising cross-functional teams to maintain strict adherence to regulatory timelines and quality protocols. Davit Abrahamyan drives the optimization of operational workflows to increase efficiency and reduce development cycles for clients. By coordinating with other senior leaders, the Managing Director ensures that regional initiatives support the broader corporate strategy. Through the management of client portfolios and project budgets, Abrahamyan secures consistent service delivery and operational excellence. The Managing Director plays a vital role in maintaining the company's reputation for reliability and scientific rigor within the competitive landscape of clinical research and development.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding ClinChoice Top Executives and Leadership Team

    Who leads ClinChoice?
    ClinChoice is led by Kevin Xu (Chairman & Chief Executive Officer), along with executives such as John Balian (ClinChoice International Chief Executive Officer) and Ling Zhen (Global Chief Executive Officer & Chairman, Board).
    Who is part of ClinChoice’s executive team?
    The executive team of ClinChoice includes leaders such as Kevin Xu (Chairman & Chief Executive Officer), John Balian (ClinChoice International Chief Executive Officer), Ling Zhen (Global Chief Executive Officer & Chairman, Board) and other senior executives.
    How many executives does ClinChoice have?
    ClinChoice has 6 executives leading key business areas.
    What roles are included in ClinChoice’s leadership team?
    The leadership team of ClinChoice includes roles such as Chairman & Chief Executive Officer, ClinChoice International Chief Executive Officer, Global Chief Executive Officer & Chairman, Board, President, Global Biometrics, Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto.